Wyeth Nutritionals: Pfizer’s New MVP, Or Benchwarmer?

Wyeth appears confident its nutritionals business will continue to grow because it is investing in new R&D facilities, mainly in emerging markets where sales opportunities are spiking.

More from Archive

More from Pink Sheet